Skip to main content

December 2016 - FRMC

News

News
01/02/2017
As public outcry over high drug prices has reached a fever pitch, drugmakers, PBMs, and payers have become caught up in a blame game over who is really responsible for the high prices of insulin products.
As public outcry over high drug prices has reached a fever pitch, drugmakers, PBMs, and payers have become caught up in a blame game over who is really responsible for the high prices of insulin products.
As public outcry over high drug...
01/02/2017
First Report Managed Care
News
12/31/2016
The nonsurgical option for candidates for surgical aortic valve replacement (SAVR) is transcatheter aortic valve replacement (TAVR) – but it comes at a cost.
The nonsurgical option for candidates for surgical aortic valve replacement (SAVR) is transcatheter aortic valve replacement (TAVR) – but it comes at a cost.
The nonsurgical option for...
12/31/2016
First Report Managed Care
News
12/30/2016
First Report Managed Care spoke to government insiders and managed care experts to tease out the complexities of the path to repeal, replace, or restructure the ACA.
First Report Managed Care spoke to government insiders and managed care experts to tease out the complexities of the path to repeal, replace, or restructure the ACA.
First Report Managed Care spoke...
12/30/2016
First Report Managed Care

Department

News Connection
12/19/2016
Study showed that Simponi Aria (golimumab; Janssen), an anti-tumor necrosis factor (TNF)-alpha therapy, was effective in treating active ankylosing spondylitis.
Study showed that Simponi Aria (golimumab; Janssen), an anti-tumor necrosis factor (TNF)-alpha therapy, was effective in treating active ankylosing spondylitis.
Study showed that Simponi Aria...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
New data suggests Bosulif (bosutinib; Pfizer Inc) is superior to imatinib as a treatment for Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).
New data suggests Bosulif (bosutinib; Pfizer Inc) is superior to imatinib as a treatment for Philadelphia chromosome positive (Ph+) chronic myeloid leukemia (CML).
New data suggests Bosulif...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
Opdivo (nivolumab; Bristol-Myers Squibb) was found to increase survival of patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Opdivo (nivolumab; Bristol-Myers Squibb) was found to increase survival of patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
Opdivo (nivolumab; Bristol-Myers...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
The safety of patients with dementia who received prescriptions through both the Veterans Affairs system and through Medicare Part D was compromised. 
The safety of patients with dementia who received prescriptions through both the Veterans Affairs system and through Medicare Part D was compromised. 
The safety of patients with...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
The American Society of Clinical Oncology (ASCO) recently published criteria for the development of high-quality clinical pathways in oncology to ensure that all clinical pathways used in oncology promote high-quality patient care. 
The American Society of Clinical Oncology (ASCO) recently published criteria for the development of high-quality clinical pathways in oncology to ensure that all clinical pathways used in oncology promote high-quality patient care. 
The American Society of Clinical...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
A federal appeals court has granted a request by House Republicans to delay the Obama administration’s appeal of a key Affordable Care Act (ACA) ruling until after President-elect Donald Trump has taken office.
A federal appeals court has granted a request by House Republicans to delay the Obama administration’s appeal of a key Affordable Care Act (ACA) ruling until after President-elect Donald Trump has taken office.
A federal appeals court has...
12/19/2016
First Report Managed Care
News Connection
12/19/2016
According to a recent announcement, President-elect Donald Trump has nominated Rep Tom Price, MD (R-GA)—a staunch opponent of the ACA—for secretary of the Department of Health and Human Services (HHS). Trump has also nominated Seema Verma—a...
According to a recent announcement, President-elect Donald Trump has nominated Rep Tom Price, MD (R-GA)—a staunch opponent of the ACA—for secretary of the Department of Health and Human Services (HHS). Trump has also nominated Seema Verma—a...
According to a recent...
12/19/2016
First Report Managed Care